BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 22677742)

  • 21. Aberrant expression of tenascin-c and neuronatin in malignant peripheral nerve sheath tumors.
    Dugu L; Hayashida S; Nakahara T; Xie L; Iwashita Y; Liu X; Uchi H; Tateuchi S; Takahara M; Oda Y; Moroi Y; Furue M
    Eur J Dermatol; 2010; 20(5):580-4. PubMed ID: 20610366
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential expression of CCN1/CYR61, CCN3/NOV, CCN4/WISP1, and CCN5/WISP2 in neurofibromatosis type 1 tumorigenesis.
    Pasmant E; Ortonne N; Rittié L; Laurendeau I; Lévy P; Lazar V; Parfait B; Leroy K; Dessen P; Valeyrie-Allanore L; Perbal B; Wolkenstein P; Vidaud M; Vidaud D; Bièche I
    J Neuropathol Exp Neurol; 2010 Jan; 69(1):60-9. PubMed ID: 20010302
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-resolution DNA copy number profiling of malignant peripheral nerve sheath tumors using targeted microarray-based comparative genomic hybridization.
    Mantripragada KK; Spurlock G; Kluwe L; Chuzhanova N; Ferner RE; Frayling IM; Dumanski JP; Guha A; Mautner V; Upadhyaya M
    Clin Cancer Res; 2008 Feb; 14(4):1015-24. PubMed ID: 18281533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hybrid schwannoma/perineurioma: clinicopathologic analysis of 42 distinctive benign nerve sheath tumors.
    Hornick JL; Bundock EA; Fletcher CD
    Am J Surg Pathol; 2009 Oct; 33(10):1554-61. PubMed ID: 19623031
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MRI features in the differentiation of malignant peripheral nerve sheath tumors and neurofibromas.
    Wasa J; Nishida Y; Tsukushi S; Shido Y; Sugiura H; Nakashima H; Ishiguro N
    AJR Am J Roentgenol; 2010 Jun; 194(6):1568-74. PubMed ID: 20489098
    [TBL] [Abstract][Full Text] [Related]  

  • 26. p53 and Ki-67 proliferating cell nuclear antigen in benign and malignant peripheral nerve sheath tumors in children.
    Liapis H; Marley EF; Lin Y; Dehner LP
    Pediatr Dev Pathol; 1999; 2(4):377-84. PubMed ID: 10347283
    [TBL] [Abstract][Full Text] [Related]  

  • 27. L1 is associated with favorable outcome in neuroblastomas in contrast to adult tumors.
    Wachowiak R; Fiegel HC; Kaifi JT; Quaas A; Krickhahn A; Schurr PG; Erttmann R; Schachner M; Kluth D; Sauter G; Izbicki JR
    Ann Surg Oncol; 2007 Dec; 14(12):3575-80. PubMed ID: 17917782
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1: a clinicopathologic and molecular study of 17 patients.
    Leroy K; Dumas V; Martin-Garcia N; Falzone MC; Voisin MC; Wechsler J; Revuz J; Créange A; Levy E; Lantieri L; Zeller J; Wolkenstein P
    Arch Dermatol; 2001 Jul; 137(7):908-13. PubMed ID: 11453810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transgenic mice overexpressing neuregulin-1 model neurofibroma-malignant peripheral nerve sheath tumor progression and implicate specific chromosomal copy number variations in tumorigenesis.
    Kazmi SJ; Byer SJ; Eckert JM; Turk AN; Huijbregts RP; Brossier NM; Grizzle WE; Mikhail FM; Roth KA; Carroll SL
    Am J Pathol; 2013 Mar; 182(3):646-67. PubMed ID: 23321323
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetically engineered mouse models shed new light on the pathogenesis of neurofibromatosis type I-related neoplasms of the peripheral nervous system.
    Brossier NM; Carroll SL
    Brain Res Bull; 2012 May; 88(1):58-71. PubMed ID: 21855613
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of p27(kip) and other cell cycle regulators in malignant peripheral nerve sheath tumors and neurofibromas: the emerging role of p27(kip) in malignant transformation of neurofibromas.
    Kourea HP; Cordon-Cardo C; Dudas M; Leung D; Woodruff JM
    Am J Pathol; 1999 Dec; 155(6):1885-91. PubMed ID: 10595919
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microscopic intraneural perineurial cell proliferations in patients with neurofibromatosis type 1.
    Agaimy A
    Ann Diagn Pathol; 2014 Apr; 18(2):95-8. PubMed ID: 24461704
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MDM2 amplification in malignant peripheral nerve sheath tumors correlates with p53 protein expression.
    Wallander ML; Tripp S; Layfield LJ
    Arch Pathol Lab Med; 2012 Jan; 136(1):95-9. PubMed ID: 22208493
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential expression of S100 protein subtypes in malignant melanoma, and benign and malignant peripheral nerve sheath tumors.
    Nonaka D; Chiriboga L; Rubin BP
    J Cutan Pathol; 2008 Nov; 35(11):1014-9. PubMed ID: 18547346
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular characterization of permanent cell lines from primary, metastatic and recurrent malignant peripheral nerve sheath tumors (MPNST) with underlying neurofibromatosis-1.
    Fang Y; Elahi A; Denley RC; Rao PH; Brennan MF; Jhanwar SC
    Anticancer Res; 2009 Apr; 29(4):1255-62. PubMed ID: 19414372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro studies of steroid hormones in neurofibromatosis 1 tumors and Schwann cells.
    Fishbein L; Zhang X; Fisher LB; Li H; Campbell-Thompson M; Yachnis A; Rubenstein A; Muir D; Wallace MR
    Mol Carcinog; 2007 Jul; 46(7):512-23. PubMed ID: 17393410
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of cathepsin K in neurofibromatosis 1-associated cutaneous malignant peripheral nerve sheath tumors and neurofibromas.
    Yan X; Takahara M; Dugu L; Xie L; Gondo C; Endo M; Oda Y; Nakahara T; Uchi H; Takeuchi S; Tu Y; Moroi Y; Furue M
    J Dermatol Sci; 2010 Jun; 58(3):227-9. PubMed ID: 20452751
    [No Abstract]   [Full Text] [Related]  

  • 38. Genetic and phenotypic characterization of tumor cells derived from malignant peripheral nerve sheath tumors of neurofibromatosis type 1 patients.
    Frahm S; Mautner VF; Brems H; Legius E; Debiec-Rychter M; Friedrich RE; Knöfel WT; Peiper M; Kluwe L
    Neurobiol Dis; 2004 Jun; 16(1):85-91. PubMed ID: 15207265
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical, pathological, and molecular variables predictive of malignant peripheral nerve sheath tumor outcome.
    Zou C; Smith KD; Liu J; Lahat G; Myers S; Wang WL; Zhang W; McCutcheon IE; Slopis JM; Lazar AJ; Pollock RE; Lev D
    Ann Surg; 2009 Jun; 249(6):1014-22. PubMed ID: 19474676
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subclassification of nerve sheath tumors by gene expression profiling.
    Holtkamp N; Reuss DE; Atallah I; Kuban RJ; Hartmann C; Mautner VF; Frahm S; Friedrich RE; Algermissen B; Pham VA; Prietz S; Rosenbaum T; Estevez-Schwarz L; von Deimling A
    Brain Pathol; 2004 Jul; 14(3):258-64. PubMed ID: 15446580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.